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ABSTRACT  
 
The aim of this study was to assess the knowledge of high school students about HPV and 
their awareness that a vaccine is available as prophylactic treatment. Nine hundred and 
eighty-six students were surveyed—the gender distribution being 61.5% female and 38.5% 
male. Of those surveyed, 67.1% said they had heard of HPV, but only 53.3% of those 
familiar with the virus knew a prophylactic treatment was available. Female students knew 
more about HPV than did their male counterparts (71.6% v. 60%), consequently fewer 
males knew of the vaccine (58.3% v. 50.7%). The students’ acceptance of the HPV vaccine 
as prophylactic treatment was correlated with both prior knowledge of the virus and the 
vaccine. Therefore, the study concluded that it is necessary to increase public awareness 
about HPV and with the availability of a the vaccine as preventative treatment. That is 
important due to a great level of resistance to vaccination in several states of Brazil. This 
study highlights the need for new public health policies.  
  
Keywords: Human papillomavirus; HPV prophylactic vaccine; Teenagers. 
 
 
RESUMO  
 
O objetivo deste estudo foi avaliar o conhecimento de estudantes do ensino médio sobre o 
HPV e sua conscientização de que uma vacina está disponível como tratamento profilático. 
Novecentos e oitenta e seis estudantes foram pesquisados - a distribuição por gênero era de 
61,5% do sexo feminino e 38,5% do sexo masculino. Dos entrevistados, 67,1% disseram ter 
ouvido falar do HPV, mas apenas 53,3% dos familiarizados com o vírus sabiam que um 
tratamento profilático estava disponível. As alunas sabiam mais sobre o HPV do que seus 
colegas do sexo masculino (71,6% vs. 60%); consequentemente, menos homens conheciam 
a vacina (58,3% vs. 50,7%). A aceitação dos estudantes da vacina contra o HPV como 
tratamento profilático foi correlacionada com o conhecimento prévio do vírus e da vacina. 
Portanto, o estudo concluiu que é necessário aumentar a conscientização do público sobre 
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o HPV e com a disponibilidade da vacina como tratamento preventivo. Isso é importante 
devido ao grande nível de resistência à vacinação em vários estados do Brasil. Este estudo 
destaca a necessidade de novas políticas públicas de saúde. 
  
Palavras-chave: Papilomavírus humano; Vacina profilática contra o HPV; Adolescentes 
 
 
1 INTRODUCTION 
The human papillomavirus infection (HPV) is one of the most common sexually 
transmitted diseases (STD) in the world with over 630 million people infected1, 2. Viral 
infection occurs mostly through sex3 (WHO, 2013), and it is estimated that about 60% to 
80% of sexually active people will be infected with the virus during their lifetime and 4% 
to 8% will have some injury related to the viral infection4, 5, 6. 
HPVs are classified according to their oncogenic potential. Mainly, they are 
classified in high and low oncogenic risk. The low risk viruses are associated to the 
development of genital warts (condylomata acuminata) in both men and women7. 
Meanwhile, persistent infection by high risk viruses is associated to the development of 
malignancies in several places such as lungs, breasts, anus, oropharynx, and particularly in 
the cervix8, 9, 10, 11. 
The precancerous cervical lesions are more observed in younger age groups, while 
cervical cancer is more commonly seen in women over 502. Cervical cancer is the second 
most common female cancer in the world and carries a high morbidity and mortality, with 
about 929,000 new cases and 275,000 annual deaths worldwide. 85% percent of cases occur 
in developing countries, such as Brazil12.  
In 1984, Brazil created the first assistance program dedicated to women's health, 
which began to establish the basis for preventive measures against breast and cervical 
cancers. A cytological analysis, known as Pap test, was chosen as the primary method of 
approach in cervical cancer prevention13. 
In March 2014, the Ministry of Health of Brazil launched a preventive campaign 
against cervical cancer through HPV vaccination. 1.1 billion reais (about 448 million USD) 
were used for the acquisition of the prophylactic quadrivalent vaccine, which protects 
against infection with the HPV types 6, 11, 16, and 18. 
The vaccination campaign targeted girls of different ages. Initially, the campaign 
targeted girls between 11 and 13 years old. In 2015 the campaign was refocused to included 
girls between 9 to 11, and in 2016 it was expanded to include all girls above the age of 9. 
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The vaccine is paid for by Brazil's health system, “Unified Health System” (SUS), and, thus, 
is free for the public. The administration of the vaccine follows a three dose schedule. 
Following the initial administration two follow-up shots are administered six months and 
five years later14. 
 However, information campaigns concerning the prevention of HPV infection, 
cervical cancer signs, and tumoral indolence were not properly performed. In addition, lack 
of knowledge about the existence of multiple HPVs types, that the vaccine only prevents 
against four types, as well as the risk of infection by other sexually transmitted diseases 
were evidenced in the students. The objective of this study was to assess the knowledge 
level of high school students from private and public schools, about cervical cancer, HPV 
and the HPV vaccine. 
 
2 MATERIAL AND METHODS 
2.1 MATERIAL AND METHODS: SITES AND SUBJECTS OF THE STUDY  
 One thousand and sixty-eight questionnaires were given to students of ages ranging 
from 13 to 19 years old in both private and public secondary schools in the state of 
Pernambuco, Brazil. Ten schools were visited but only 6 of them agreed to take part in the 
research project. Two schools were assessed in each city, one in the private and other in the 
public sector. The schools were located at the capital city, Recife, as well at the towns of 
Amaraji and São Lourenço da Mata in the state of Pernambuco, representing mesoregion 
areas: Zona da Mata (Amaraji) and the Recife metropolitan area (Recife and São Lourenço 
da Mata). 
 Data collection was performed through questionnaires which were divided into two 
parts: socioeconomic status and specific knowledge. The research was conducted between 
August 2013 and February 2014 and compiled according to all the established ethical 
guidelines. There was no way of identifying the interviewees, participation in the study was 
voluntary, and processed data was for the sole use of the researchers. 
 
2.2  EVALUATION QUESTIONNAIRES 
 After an extensive review of the literature, a confidential questionnaire containing 
34 questions (which were easy to read and self-explanatory) was applied by the laboratory 
team itself. Eleven of the questions were on socioeconomic matters, and the 23 that followed 
concerned the topics being explored in this study. The questions designed to determine the 
Brazilian Journal of health Review 
 
 Braz. J. Hea. Rev., Curitiba, v. 2, n. 6, p.6145-6160   nov./dec. 2019.   ISSN 2595-6825 
 
 
6149  
socioeconomic status of the students were based on the 2010 Census conducted by IBGE 
(Brazilian Institute of Geography and Statistics), the official Brazilian census agency. This 
study examined the following categories: (1) gender; (2) ethnicity; (3) monthly household 
income; (4) knowledge about HPV; (5) information sources about HPV; (6) knowledge 
about the vaccine; (7) willingness to be vaccinated, should it be available. 
 
2.3  DATA COLLECTION  
 The students who agreed to take part in the research were given the questionnaires 
and the instructions on how to answer them. Doubts raised during questionnaire filling were 
clarified by the researchers themselves. After the questionnaires had been completed and 
collected, the students attended an explanatory lecture which covered all the issues 
contained in the assessment: HPV, uterine cancer, and methods of diagnosis and prevention. 
 
2.4  STATISTICAL ANALYSIS  
 After data collection, statistical analysis was done through the Statistical Package 
for the Social Sciences (SPSS) Statistics 20. The basic statistics description and frequency 
calculations were carried out for all the variables. The relation between categorical variables 
was measured by means of Pearson’s Chi-Square Test and Exact Test Fisher. The statistical 
significance was 0.05 during the course of the study. 
 
3 RESULTS 
3.1 SOCIOECONOMIC CHARACTERISTICS  
 One thousand and sixty-eight teenagers from six secondary schools were 
interviewed. However, the lack of coherence of some answers reduced the number of valid 
questionnaires to 986. The results on gender, ethnicity, and monthly household income can 
be observed in table 1. 
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Table 1. Socioeconomic status of students enrolled in the research. 
Socioeconomic characteristics 
Gender 
Male 380 (38.50%) 
Female 606 (61.50%) 
Ethnicity 
Brown 478 (48,50%) 
White 340 (34.50%) 
Black              90 (9.10%) 
Asian 38 (3.90%) 
Indigenous 20 (2.00%) 
Uninformed 20 (2.00%) 
Household income 
Less than 1 minimum wage 218 (22.10%) 
Between 1 and 3 minimum 
wages 
481 (48.80%) 
Between 3 and 5 minimum 
wages 
130 (13.18%) 
More than 5 minimum wages 91 (9.20%) 
Uninformed  66 (6.70%) 
 
 
4 KNOWLEDGE OF HPV  
Of the 986 students interviewed, 67.1% reported having heard about HPV (Table 2). 
The results have shown that there is a significant difference between the knowledge about 
the virus when comparing males and females. Statistical analysis showed no significant 
difference when comparing different ethnic groups (p= 0.345) and household income (p= 
0.252) on the knowledge about HPV. 
 
Table 2. Knowledge of the students about HPV. 
 
 
 
 
 
 
               p* = Shared knowledge about HPV between males and females. 
 
 
 
Knowledge of HPV p* 
They heard speak 67.10% (662/986)  
Male 60.00% (228/380)  
0.0002* 
Female 71.62% (434/606) 
Never heard of 32.90% (324/986)  
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5 KNOWLEDGE OF THE HPV VACCINE 
The 662 students who stated that they had heard people talk about HPV, were 
divided into three groups (A, B and C): group A—knew about the prophylactic vaccination 
against the virus; group B—stated that they had heard people talk about HPV, but were 
ignorant about the prophylactic vaccination; and group C—gave no answer on this matter 
(table 3). 
 
Table 3. Knowledge about the prophylactic HPV vaccine. 
 
 
 
 
 
 
 
 
 
p * = Knowledge about the vaccine between the male and female genders. 
p ** = Knowledge about the vaccine between groups A and B. 
 
Female students exhibited a greater knowledge about HPV and about the 
vaccination, but when males and females were not aware of the virus, no observable 
difference in knowledge was identified. In addition, it was possible to observe that there 
was no statistically significant difference between groups A and B concerning knowledge 
about the vaccine. 
 
6 PROPHYLACTIC VACCINE COMPLIANCE FOR HPV  
The vaccine had a good acceptance among students, as shown in table 4. The data 
disclosed that there was a good acceptance of the vaccine and that there was no statistically 
significant difference in acceptance when comparing males and females and when 
comparing groups A and B. 
Knowledge about the vaccination p* p** 
Group A   45.20% (299/986)  
0.0737 
Male   23.95% (91/380)  
0.0006* 
Female 34.32% (208/606) 
Group B 53.30% (353/986)   
Male 35.00% (133/380)  
0.6829 
Female  36.30% (220/606) 
 Group C    1.50% (10/986)    
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Table 4. Acceptance of prophylactic vaccine against HPV by students. 
 
p * = Relation of acceptance of the vaccine between male and female. 
p ** = Results of vaccine acceptance between group A and B. 
 
7  SOURCES OF INFORMATION OBTAINED ABOUT HPV 
As for the sources of information, considering the number of students who had 
knowledge of HPV, it was verified that the main source was television, corresponding to 
30.50% of sources, closely followed by the school, with 22.30%. The internet was the source 
cited for 17% of the interviewed students (table 5). 
Table 5. Sources of information through which students gained knowledge about HPV. 
 
 
 
 
 
  
 
 
 
 
8 DISCUSSION 
The aim of this study was to assess the level of knowledge that secondary school 
students had of cervical cancer, HPV, and prophylactic vaccinations against HPV. The 
target public covered secondary school students from both the private and public sectors, 
Willingness p* p**  
Group A 74.90% (224/299)  
0,6546 
Male 75.80% (69/91) 
0.8852 
Female 74.50% (155/208) 
Group B 73.00% (258/353)  
Male 70.60% (94/133) 
0.3896 
Female 74.50% (164/220) 
Information sources 
TV 30.50% (202/662) 
School 22.30% (148/662) 
Internet 17.00% (113/662) 
Family / Friend 10.60% (70/662) 
Health professional 10.00% (66/662) 
Journal / Newspaper 6.10% (40/662) 
Others 3.50% (23/662) 
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located in two of the five mesoregions of the State of Pernambuco: Zona da Mata and the 
Recife metropolitan area. 
The data obtained from the socioeconomic questionnaire showed that most of the 
students were girls (61.5%), a large number of them being brown-skinned (48.5%) or white 
(34.5%). Regarding their monthly household income, almost half of the teenagers (48.8%) 
stated that they had a family income ranging between one and three times the current 
minimum wage in Brazi, equivalent to aproximately US$ 246. This information, obtained 
from a sample that reflects two mesoregions of the State of Pernambuco, is consistent with 
the most recent data obtained from IBGE for the State15. 
Regarding knowledge of HPV, this study found that 67.1% of the students 
interviewed had already heard of HPV. This percentage was much higher than those found 
in similar studies that involved groups at the same age. A study conducted by a Swedish 
research group found that in a sample of 608 students of first year upper secondary school, 
15- 16 years old, only 82 (13.5%) had heard of HPV16. 
Another study conducted in Xiangtan City of Hunan Province in China covered 848 
teenagers, only 10.1% of whom had heard of the virus17. This finding can be attributed to 
the system of education prevailing in China, where the free time of the students is 
supplemented with other fields (such as science and the arts); health education is generally 
neglected and, thus, there is a prevailing ignorance of sexually transmitted diseases. Marek 
et al. also reported a limited knowledge of the virus (35%) in a study carried out on a sample 
of 1,769 students of public primary and secondary schools in 16 Hungarian cities and towns, 
covering each of the 7 administrative regions of Hungary, over a five month period18. 
According to the researcher, the prioritization of AIDS/HIV in the sex education 
curriculum diverts students from obtaining knowledge of other STDs, including HPV, 
which is a much more common infection. However, the figures shown in this study are 
slightly lower than those from a recent study in Latin America carried out over a two month 
period with 533 students from grades 7-12 from five public high schools in the rural San 
Carlos region. 75.2% of the students had heard of HPV, but a very limited correlation was 
observed in the students’ knowledge of the relationship between the virus and cervical 
cancer19. 
Our data suggested that there was a greater lack of knowledge about HPV among 
male than female students (71.62% v. 60.0%) (p=0.0002); ergo, there was a slightly larger 
knowledge about the prophylactic HPV vaccine among females than males (34.32% v. 
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23.95%) (p=0,0006). Studies conducted with teenagers of both sexes have found that girls 
tend to have more information about HPV and vaccinations20, 21. This can probably be 
attributed to the fact that girls are often more precocious in seeking sexual health guidance 
from healthcare professionals, such as through gynecologist appointments. The fact that 
girls were, on the time of the data collection, the targeted group by the governmental 
vaccination program should also be considered as a possible contributor for this variation. 
In this study, the most cited source of information about the virus was television 
(30.5%) and school (22.3%). In a study carried out in Hungary, it was also found that 
television was the source most often mentioned (approximately 45%), and a quarter of the 
students stated that they had heard of HPV in lessons or presentations given in school18. 
This was also observed in another study performed with male undergraduates in the US in 
which advertisements on TV were mentioned in 58.8% of all the references made22. 
Of all the students who were aware of the HPV, over a half (53.3%) did not know 
about the prophylactic vaccination. Studies involving teenagers of the same age groups in 
China, Sweden, and Hungary also revealed a large lack of information about the 
vaccination, with more preponderent levels of ignorance than those found in this study: 
90.9%, 94% and 70%, respectively16, 17, 18.  
Generally speaking, when these authors discussed the extent of knowledge about the 
prophylactic vaccination and its resulting degree of acceptance, they linked it to their 
previous knowledge of HPV, which tended to be low. Gotvall et al. discussed the probable 
increase in knowledge about the vaccination and the willingness to be vaccinated of some 
students after the implementation of the HPV vaccination program, which would be put into 
effect two years after their research project was finalized in Sweden. Moreover, Marek et 
al. examined why knowledge about it was not as high as expected, although the vaccine had 
been available three years before their study was conducted in Hungary. They attribute this 
to the failure of the media to reach out to teenagers during the vaccination campaign. 
While this study was undertaken, the Brazilian Ministry of Health was conducting a 
vaccination campaign for children aged between 11 and 13 which began in March 2014, 
through advertising on television, in newspapers, and the Internet. It addressed the following 
issues: HPV, uterine cancer, and vaccination. This valuable information, made available by 
Brazilian TV, explains the increase in the percentage of teenagers who mentioned that they 
had heard of the virus, as well as the vaccine. Hence, television was the main means 
disseminating the information. 
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It could be argued that the monthly household income had no influence on the 
knowledge of HPV (p= 0.252). Similarly, knowledge about the virus was not influenced by 
the different ethnic groups to which the students belonged (p= 0.345). This finding differs 
from the ones observed in two studies carried out with women in the United States, which 
revealed that black women had less knowledge about the virus than their white 
counterparts23, 24. 
This study has also confirmed that whether the students came from the metropolitan 
region or the capital did not influence their degree of knowledge of HPV (p= 0.570). 
Regarding this, Li et al. found a disparity between women in rural areas and residents in the 
metropolitan areas of China (9.3% vs 25,6%)25.  
Of all the students who knew about HPV and the vaccine, 74.9% were willing to be 
vaccinated, should it be available. The rates of vaccination acceptance between those who 
have heard of the vaccine and those who only have a restricted knowledge of HPV were 
close (74.90% and 73.00%, respectively). When comparing towns/cities and genders under 
study, the variation on the acceptance rate remains small. In their study, Gottvall et al 
recorded a higher rate of students among the total number of interviewees (84%) who were 
willing to be vaccinated, although it was noted that 73% of these stated that they would have 
liked to have more information before making a decision16. 
It is known that the vaccine is prophylactic and not therapeutic. It is also known that 
it does not give protection against every type of HPV that has the potential to cause 
neoplastic lesions26. It has been stated that there are other high-risk virus types such as HPV 
31, the second most prevalent type of HPV in our State27, 28, which is not prevented by the 
available vaccine29. That reveals a flaw in the governmental plan of vaccination; Likewise 
the data reveals insufficiency on the government’s vaccination campaign (only 67.10% of 
the interviewed students had any knowledge of the vaccine) - which might have led to a low 
number of young people adhering to the vaccination program that cost more than a billion 
reais to be implemented. Measures such as disseminating information during the vaccination 
campaign, not only by television broadcasts but steadily, for example, including courses on 
the subject in the school syllabus could be useful for better widespread propagation of 
information about the matter. 
The HPV and prophylactic vaccination related findings were highlighted in this 
study so that they could be compared to studies from foreign countries which were also 
realized with students of secondary schools of the same age group. However, this study did 
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not cover issues such as the knowledge of the students about the links between HPV and 
cervical cancer; recognition of human papillomavirus infection as a sexually transmissible 
disease; or the sexual behavior of students in the light of this knowledge. 
 
9 CONCLUSION  
The assessed students had a high degree of knowledge about HPV and a considerable 
knowledge of the existence of the HPV vaccine. However, there should be broader studies 
about the knowledge and attitudes of students of the same age when faced with the virus 
and the recently launched vaccination program. The HPV vaccination program has shown 
serious gaps regarding its efficiency. There is also a need to make campaigns aiming to 
broaden teenagers’ knowledge about the issues addressed here. This could lead to greater 
acceptance of prevention programs, as well as to allow them to become permanent in the 
routine vaccination schedules. As a result, it would be possible to form a basis for adopting 
new strategies and policies for more effective and wide-ranging prevention schemes, as well 
as to provide information that can lead to a heightened awareness of the virus and its severe 
effects, once students of this age group have the potential to spread this information to other 
young people of their age, from direct interaction with them in schools or in their 
neighborhood, or in a less direct way, such as through publications in social networks.  
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